Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$21.65 - $39.49 $14.6 Million - $26.6 Million
-674,723 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $6.47 Million - $9.38 Million
417,223 Added 162.03%
674,723 $14.1 Million
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $2.97 Million - $4.45 Million
200,000 Added 347.83%
257,500 $5.19 Million
Q4 2020

Feb 12, 2021

BUY
$9.4 - $16.7 $537,482 - $954,889
57,179 Added 17812.77%
57,500 $870,000
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $3,383 - $8,012
321 New
321 $3,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.